Purdue Pleads Guilty in Criminal Court

Purdue Pharma, the drugmakers responsible for Oxycontin, pleaded guilty to criminal charges this afternoon. The charges are related to the drug,  a highly addictive narcotic that has been a primary driver of the opioid epidemic.

Previous Oxycontin Lawsuits

The guilty pleas in the criminal case came after a settlement last month

In October, the Sackler Family (owners of Perdue) were handed an eight billion dollar judgment, a settlement combining thousands of lawsuits from cities, states, and counties. (Not every locality suing Perdue signed off on the settlement, and some were paid out separately, including New York, which received several billion of its own.) Purdue has filed for bankruptcy and may be restructured and overseen by the government as the Sacklers remove themselves from the business.

Perdue’s Criminal Charges

In today’s world, corporations are treated as people. It may be surprising …

Continue Reading Purdue Pleads Guilty in Criminal Court

25 State Attorneys Oppose Oxy Settlement

  • Post author:
  • Post category:big pharma
  • Reading time:2 min(s) read

Twenty-five State attorneys have signed a letter opposing any settlements between the Justice Department and Purdue Pharmaceutical, Oxycontin’s manufacturers.

Purdue, owned by the infamous Sackler family, is preparing to settle a lawsuit with dozens of cities and counties across the United States. The suit itself is over their aggressive marketing and obfuscation with their addictive drug Oxycontin.

The Argument Against the Settlement

The attorneys say that the settlement does more harm than good. By forcing the state to oversee the settlement, the settlement will “improperly entangle state and local officials with future sales of the company’s addictive pain drug OxyContin.” The Justice Department has stipulated that Purdue transforms itself into a “public benefit company.” By becoming such an establishment, it would be run “on behalf” of the cities, states, and counties who are suing it.

The company, therefore, would need …

Continue Reading 25 State Attorneys Oppose Oxy Settlement
FDA Targets Illegal Website Sales of Tramadol
website selling tramadol

FDA Targets Illegal Website Sales of Tramadol

  • Post author:
  • Post category:U.S. government
  • Reading time:3 min(s) read

The US Food and Drug Administration has issued a warning to website operators for the illegal sales of the opioid Tramadol. According to the letters sent to operators, some of the drugs were mislabeled, while others were not approved for sale in the United States. All of the websites are illicit and selling opioids without prescriptions.

FDA Cracking Down 0n Tramadol

While it may seem to be a minor way censure to have an FDA letter sent to a website, it’s the first action the agency typically takes. The FDA’s letter also clearly states that they are taking action, which means the letter is the first step.

The FDA’s primary job is to make sure that our foods and drugs stay safe. They do not have the authority to arrest website operators. However, they often bring the DEA and other …

Continue Reading FDA Targets Illegal Website Sales of Tramadol

Fake Oxycontin is Killing People

Fake Oxycontin is a big trend on the streets in America, and investigators in Minnesota say they’re the cause of fatal overdoses. Usually, they’re laced with fentanyl, which can be fifty to a hundred times as potent than morphine.

Fake But Deadly

In St. Cloud, Minnesota, a recent overdose came from fentanyl marketed on the street as Oxycontin. Some fentanyl has also been passed off to be Oxycodone or Percocet. It’s a nationwide trend in recent months, as drug traffic has stalled at the border during a national pandemic.

The pills are made to look like the real pill, although some have a blueish tint to them. One side of the tablet is blue with the “M” stamped on one side and “30” stamped on the other.

Last month, a Sacramento resident was caught with over 1,000 pills of what …

Continue Reading Fake Oxycontin is Killing People

FDA Adds Naloxone Info to Opioid Scripts

  • Post author:
  • Post category:legislation
  • Reading time:3 min(s) read

The Food and Drug Administration announced a new requirement for drugmakers to help inform consumers about naloxone. Naloxone is a drug that helps reverse opioid and other drug overdoses. The new rule means that every prescription drug containing opioids will now include information about naloxone.

The naloxone notice is just one small thing that they’re hoping will help people stay alive during the pandemic. People who are abusing opioids may not be aware that it’s an option. Many people are isolated from other drug users and staying home during the pandemic.

Overdoses Are Increasing During Pandemic

Drug overdoses are multiplying quickly during the age of COVID-19, and numbers of deaths were higher than ever in 2019 before the pandemic even touched American lives.

Public health officials have warned the public and doctors to expect significant increases in “deaths of

Continue Reading FDA Adds Naloxone Info to Opioid Scripts

AMA Says Opioid Crisis Worsened By COVID-19

The American Medical Association put out an article this week about the opioid epidemic. Just like other public health crises, opioid addiction seems to be on the backburner. Yet people who are addicted to opioids are more vulnerable to COVID-19.

In many places, both the COVID-19 crisis and the opioid epidemic are currently both causing casualties. In the state of Illinois, DuPage County has suffered 315 deaths so far this year from the novel coronavirus. But the agency also reports that there have been 303 overdoses reported in the Emergency Room this year.

Last year, 96 people overdosed on opioids. But the numbers are growing for 2020. For three weeks between April and May, the county experienced 22 fatal overdoses.

Fewer Resources For Addicted During COVID-19

Many of the people who overdosed in Dupage County were alone and practicing social …

Continue Reading AMA Says Opioid Crisis Worsened By COVID-19

Research Proves Opioid Agonists Prevent OD’s and Relapse

 

Using Medication-Assisted Treatment once carried stigma in the recovery community. However, recent research has shown how much these aspects of treatment can save lives. Opioid agonists keep people from relapse and overdose death.

Many people have a lack of understanding about why the drug is useful or how it helps people begin the path to recovery. This stigma can keep people from getting the help they need to stay clean and sober. This is a big gap in the recovery world, unfortunately. A lack of MAT options could mean the difference in recovery versus relapse. Researchers say that one group of MAT options, opioid antagonists, are especially effective when used by people new to recovery.

What Are Opioid Agonists?

Opioid agonists help people with heroin or prescription opioid use disorder abstain from those drugs. In recovery, doctors may prescribe …

Continue Reading Research Proves Opioid Agonists Prevent OD’s and Relapse

Does the Dental Industry Has an Opioid Script Problem?

Recent studies show that the dental industry in America may be an essential link in the addiction crisis, with nearly half of dental prescriptions exceeding prescription guidelines for acute pain management.

The research, published today in the American Journal of Preventative Medicine, covered a five-year study period of dental prescriptions.

What Do the Numbers Say?

Dentists are a vital component in addiction prevention that has often been overlooked in research studies. However, the dental industry is responsible for 10% of all opioid prescriptions in the United States. Yet, in three out of ten prescriptions, dentists prescribed a more powerful opioid than necessary following painful procedures. And the prescriptions were typically for longer than three days, which is the current opioid prescription guideline for acute surgery pain.

For the study, the researchers analyzed data on nearly 550,000 dental visits by …

Continue Reading Does the Dental Industry Has an Opioid Script Problem?

FDA Studies On Opioid Education Were Flawed

Studies on doctor education in the opioid epidemic were flawed, and hindsight, as they say, is 20/20. And although the FDA has lobbied heavy criticism and the pharmaceutical industry has paid fines, they are not without blame. They took years to investigate the makers and distributors of Oxycontin. Instead of protecting consumers, the federal agency instead left its own bumbling paper trail for opioid education oversight, according to a New York Times report.

The FDA, documents reveal, did little to stop overprescribing and, in fact, created a study that failed to be accurate by design, according to Caleb Alexander, the senior author of the study. “It’s unclear why the FDA didn’t insist upon a more scientifically rigorous evaluation of this safety program.” This means that it’s unclear if any studies were correct.

What Studies Were Done on the Safety

Continue Reading FDA Studies On Opioid Education Were Flawed

Oxycontin Makers Sink Claws Into China

A report has come out detailing the marketing moves that Purdue Pharma, the drugmaker responsible for Oxycontin and other variations of opioid, has moved on to China. Of course, it’s no big secret that companies like food and pharmaceutical makers take their wares overseas to new markets.

What’s unusual about Purdue’s business moves is that the behavior that cost billions of dollars in US lawsuits is now being deployed in China.

Boosting Sales and Breaking Laws in China

Stat News claims that when sales began to crash due to the opioid crisis, the Sacklers and their subsidiaries set their eyes on the global market. In China, Purdue’s international pharma dealer, Mundipharma, pushed for profits over ethics without fail. While the profit scheme unraveled very publicly in the US courts, quietly, Purdue Pharma began marketing elsewhere.

Current and former employees told …

Continue Reading Oxycontin Makers Sink Claws Into China